Last Updated2026-06-02

Market View

₹2,249.8(▼0.58%)

Reporting PeriodQ4 FY26

LUPINLupin Limited Forensic Risk Analysis

Name: Lupin Limited Structural Risk Analysis
Creator: Flagium AI
License: https://creativecommons.org/licenses/by-nc-nd/4.0/

Pharmaceuticals

Risk ClassStable

Market Cap₹1,05,897 Cr

Primary DriverGovernance

Flagium AI Risk Score

0 / 100

0 QoQ

Stable

Sentinel Insight

Financial profile remains stable for now. Pressure has stabilized in governance. This indicates that forensic pressure is currently receding. No major change in risk trend.

0.0th %ile (Sector)Accel: +0 Qtrs

Updated2026-06-02

Market View

₹2,249.8▼0.58%

PeriodQ4 FY26

Score Waterfall
Absolute contribution points of each forensic pillar to the final risk score. Derived from: Sector Baseline + Active Penalties - Mitigation Buffers.

No active forensic penalties contributing.

Final Composite Risk0 / 100

Investment Risk Thesis

Historical Trend

Current risk score has declined from 0 → 0 over 12 quarters.

Expected Direction

⚠ Watch

Primary Deterioration Drivers

Working Capital Expansion

What to Watch Next Quarter

Working capital efficiency

Active Risk Objects (1)

CriticalHigh

Working Capital Expansion

💧 Liquidity & CoverageAnnualActive for 2 Years

More Detail

Impact Weight10/15

MomentumDecaying

Last SignalQ4 FY2025

Working capital expansion detected: Receivable days increased by 2.1%.

"Working capital pressure is receding. Cash previously locked in operations is being released."

Risk Trajectory

Loading Chart

Resilience Matrix

Metric	Value	vs Sector	Signal
Volatility (σ)	1.82	7.70	✅ RESILIENT
Sensitivity (ε_s)	1	1.00	✅ RESILIENT
Escalation Prob.	5%	5%	✅ NEUTRAL
Safety Buffer	+66.0	+47.0	✅ RESILIENT

Forensic Benchmark Context: Pharmaceuticals (n=99 peers)

Correlation Analysis
Visualizing the relationship between stock price movement and structural risk objects.

Loading Chart

Share Price

Risk Score (0-100)

Market Performance

₹2,249.8(-0.58%)

1M Divergence-4.67%

1 Week-0.71%

1 Month-2.4%

6 Months+7.54%

1 Year+15.43%

2 Year+43.67%

3 Year+179.52%

Sector Average (1M)+2.27%

Sentinel Forensic Assessment

ALGORITHMIC RISK PROFILE • NON-ADVISORY

The structural architecture is currently robust. Capital resilience buffers in governance remain well-maintained against forensic benchmarks. Systematic scans of structural transparency and audit trails confirm the absence of material structural stress. The current structural trajectory supports a stable risk outlook.

LUPIN • MARKET STRUCTURE

Stage 2 — Advancing

The company is in a growth phase. Institutional sentiment is highly positive, supported by strong fundamentals and sustained risk reduction.

Stage Transition Prob.95%

Trend QualityDeveloping

Phase Progression

Phase Progression Score65%

Readiness LabelModerate (Transition Potential Building)

Probability of Advancing95%

CoinTree Momentum

Composite Z-Score-0.2557σ

Weakening momentum trend

Universe Rank#1557 of 2716

Top 57.33% in momentum strength

Timeframe Sparklines

1W-0.7%

1M-2.4%

6M+7.5%

Weinstein Indicators

150 DMA₹2,191.2

200 DMA₹2,133.54

150 DMA Slope+2.1399%Rising

Relative Strength+13.03%Leading

Relative Turnover (RTR)1.4598

ParticipationHealthy

PEER COMPARISON

Ranked comparison against sector peers

This company appears relatively stable compared to the Sector Mean (19).

Ticker	Risk Score	Sector %ile	Delta	Flags	Accel	Primary Driver
LUPINLupin Limited	0	0th	0	1	+0	GovernanceStable
ABBOTINDIAABBOTINDIA	0	0th	0	0	+0	GovernanceStable
AARTIDRUGSAarti Drugs Limited	19	51th	-5	11	+0	Competitive PositionStable
AAREYDRUGSAarey Drugs & Pharmaceuticals Limited	23	63th	-5	20	+0	Balance Sheet StressWatch